Attenuating Epithelial‐to‐Mesenchymal Transition in Cancer through Angiopoietin‐Like 4 Inhibition in a 3D Tumor Microenvironment Model
Advanced Healthcare Materials · 2024
DOI: 10.1002/adhm.202303481 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Zehuan Liao und 14 weiteren Autor:innen. Beteiligte Einrichtung: School of Biological Sciences, Nanyang Technological University Singapore, 60 Nanyang Drive, Singapore, 637551, Singapore. Hauptthemen laut MEDLINE: Mechanotransduction, Cellular, Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 74 Literaturangaben.
Abstract (Originalsprache)
Epithelial‐to‐mesenchymal transition (EMT) plays a crucial role in metastatic cancer progression, and current research, which relies heavily on 2D monolayer cultures, falls short in recapitulating the complexity of a 3D tumor microenvironment. To address this limitation, a transcriptomic meta‐analysis is conducted on diverse cancer types undergoing EMT in 2D and 3D cultures. It is found that mechanotransduction is elevated in 3D cultures and is further intensified during EMT, but not during 2D EMT. This analysis reveals a distinct 3D EMT gene signature, characterized by extracellular matrix remodeling coordinated by angiopoietin‐like 4 (Angptl4) along with other canonical EMT regulators. Utilizing hydrogel‐based 3D matrices with adjustable mechanical forces, 3D cancer cultures are established at varying physiological stiffness levels. A YAP:EGR‐1 mediated up‐regulation of Angptl4 expression is observed, accompanied by an upregulation of mesenchymal markers, at higher stiffness during cancer EMT. Suppression of Angptl4 using antisense oligonucleotides or anti‐cAngptl4 antibodies leads to a dose‐dependent abolishment of EMT‐mediated chemoresistance and tumor self‐organization in 3D, ultimately resulting in diminished metastatic potential and stunted growth of tumor xenografts. This unique programmable 3D cancer cultures simulate stiffness levels in the tumor microenvironment and unveil Angptl4 as a promising therapeutic target to inhibit EMT and impede cancer progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biological Sciences, Nanyang Technological University Singapore, 60 Nanyang Drive, Singapore, 637551, Singapore.
- Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, 17177, Sweden.
- Lee Kong Chian School of Medicine, Nanyang Technological University Singapore, Clinical Sciences Building, 11 Mandalay Road, Singapore, 308232, Singapore.
- School of Materials Science and Engineering, Nanyang Technological University, Singapore, 639798, Singapore.
- Department of Biomedical Engineering, National University of Singapore, Singapore, 117583, Singapore.
- Institute for Health Innovation and Technology, National University of Singapore, Singapore, 117599, Singapore.
ORCID-Profile: Nguan Soon Tan
Zitieren
APA
Liao, Z., Lim, J. J. H., Lee, J. X. T., Chua, D., Vos, M. I. G., Yip, Y. S., Too, C. B., Cao, H., Wang, J. K., Shou, Y., Tay, A., Lehti, K., Cheng, H. S., Tay, C. Y., & Tan, N. S. (2024). Attenuating Epithelial‐to‐Mesenchymal Transition in Cancer through Angiopoietin‐Like 4 Inhibition in a 3D Tumor Microenvironment Model. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202303481
Vancouver
Liao Z, Lim JJH, Lee JXT, Chua D, Vos MIG, Yip YS, et al. Attenuating Epithelial‐to‐Mesenchymal Transition in Cancer through Angiopoietin‐Like 4 Inhibition in a 3D Tumor Microenvironment Model. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202303481
BibTeX
@article{Liao2024,
author = {Liao, Zehuan and Lim, Joseph Jing Heng and Lee, Jeannie Xue Ting and Chua, Damien and Vos, Marcus Ivan Gerard and Yip, Yun Sheng and Too, Choon Boon and Cao, Huan and Wang, Jun Kit and Shou, Yufeng and Tay, Andy and Lehti, Kaisa and Cheng, Hong Sheng and Tay, Chor Yong and Tan, Nguan Soon},
title = {Attenuating Epithelial‐to‐Mesenchymal Transition in Cancer through Angiopoietin‐Like 4 Inhibition in a 3D Tumor Microenvironment Model},
journal = {Advanced Healthcare Materials},
year = {2024},
doi = {10.1002/adhm.202303481}
}
EUVIMED